These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9235945)

  • 1. Transduction of activation signal that follows HIV-1 binding to CD4 and CD4 dimerization involves the immunoglobulin CDR3-like region in domain 1 of CD4.
    Briant L; Signoret N; Gaubin M; Robert-Hebmann V; Zhang X; Murali R; Greene MI; Piatier-Tonneau D; Devaux C
    J Biol Chem; 1997 Aug; 272(31):19441-50. PubMed ID: 9235945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The protein tyrosine kinase p56lck is required for triggering NF-kappaB activation upon interaction of human immunodeficiency virus type 1 envelope glycoprotein gp120 with cell surface CD4.
    Briant L; Robert-Hebmann V; Acquaviva C; Pelchen-Matthews A; Marsh M; Devaux C
    J Virol; 1998 Jul; 72(7):6207-14. PubMed ID: 9621091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ick protein tyrosine kinase is not involved in antibody-mediated CD4 (CDR3-loop) signal transduction that inhibits HIV-1 transcription.
    Coudronnière N; Corbeil J; Robert-Hebmann V; Mesnard JM; Devaux C
    Eur J Immunol; 1998 May; 28(5):1445-57. PubMed ID: 9603449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antibody that binds domain 1 of CD4 inhibits replication of HIV-1, but not HTLV-I, in a CD4-positive/p56lck-negative HTLV-I-transformed cell line.
    Lemasson I; Briant L; Hague B; Coudronnière N; Heron L; David C; Rebouissou C; Kindt T; Devaux C
    J Immunol; 1996 Jan; 156(2):859-65. PubMed ID: 8543843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Location of CD4 dimerization site explains critical role of CDR3-like region in HIV-1 infection and T-cell activation and implies a model for complex of coreceptor-MHC.
    Langedijk JP; Puijk WC; van Hoorn WP; Meloen RH
    J Biol Chem; 1993 Aug; 268(23):16875-8. PubMed ID: 8043041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
    Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synthetic CD4 exocyclic CDR3.AME(82-89) inhibits NF-kappaB nuclear translocation, HIV-1 promoter activation, and viral gene expression.
    Roland J; Berezov A; Greene MI; Murali R; Piatier-Tonneau D; Devaux C; Briant L
    DNA Cell Biol; 1999 Nov; 18(11):819-28. PubMed ID: 10595395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
    Broder CC; Berger EA
    J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4.
    Benkirane M; Schmid-Antomarchi H; Littman DR; Hirn M; Rossi B; Devaux C
    J Virol; 1995 Nov; 69(11):6904-10. PubMed ID: 7474107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway.
    Popik W; Pitha PM
    Mol Cell Biol; 1996 Nov; 16(11):6532-41. PubMed ID: 8887682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases.
    Bossis G; Salinas S; Cartier C; Devaux C; Briant L
    FEBS Lett; 2002 Apr; 516(1-3):257-64. PubMed ID: 11959143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.
    Bérubé P; Barbeau B; Cantin R; Sékaly RP; Tremblay M
    J Virol; 1996 Jun; 70(6):4009-16. PubMed ID: 8648738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-kappa B and AP-1 transcription factors.
    Briant L; Robert-Hebmann V; Sivan V; Brunet A; Pouysségur J; Devaux C
    J Immunol; 1998 Feb; 160(4):1875-85. PubMed ID: 9469449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors.
    Moutouh L; Estaquier J; Richman DD; Corbeil J
    J Virol; 1998 Oct; 72(10):8061-72. PubMed ID: 9733846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions.
    Ohki K; Kimura T; Jones IM; Morita F; Ikuta K
    Vaccine; 1994 Mar; 12(4):343-50. PubMed ID: 8178557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides derived from the CDR3-homologous domain of the CD4 molecule are specific inhibitors of HIV-1 and SIV infection, virus-induced cell fusion, and postinfection viral transmission in vitro. Implications for the design of small peptide anti-HIV therapeutic agents.
    Rausch DM; Hwang KM; Padgett M; Voltz AH; Rivas A; Engleman E; Gaston I; McGrath M; Fraser B; Kalyanaraman VS
    Ann N Y Acad Sci; 1990; 616():125-48. PubMed ID: 2078014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional epitope analysis of the human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4.
    Benkirane M; Hirn M; Carrière D; Devaux C
    J Virol; 1995 Nov; 69(11):6898-903. PubMed ID: 7474106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
    Shatrov VA; Ratter F; Gruber A; Dröge W; Lehmann V
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1209-16. PubMed ID: 8870842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ig CDR3-like region of the CD4 molecule is involved in HIV-induced syncytia formation but not in viral entry.
    Corbeau P; Benkirane M; Weil R; David C; Emiliani S; Olive D; Mawas C; Serre A; Devaux C
    J Immunol; 1993 Jan; 150(1):290-301. PubMed ID: 7678031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains.
    Del Real G; Jiménez-Baranda S; Lacalle RA; Mira E; Lucas P; Gómez-Moutón C; Carrera AC; Martínez-A C; Mañes S
    J Exp Med; 2002 Aug; 196(3):293-301. PubMed ID: 12163558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.